Brexanolone (Zulresso) for Postpartum Depression
The Carlat Psychiatry Report, Volume 17, Number 6&7, June 2019
Talia Puzantian, PharmD, BCPP
Chris Aiken, MD
Drs. Puzantian and Aiken have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Every week of depression takes a toll on infant development, so this rapid-acting treatment fills a unique need. Here we review the clinical data and the pragmatics of getting patients connected with the therapy.